Standout Papers
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (2014)
- A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡ (2004)
- Acute liver failure (2008)
- Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease (2018)
Immediate Impact
3 by Nobel laureates 1 from Science/Nature 143 standout
Citing Papers
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
2023 Standout
Works of Edward Doo being referenced
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡
2004 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Edward Doo | 3631 | 5073 | 340 | 1258 | 41 | 6.5k | |
| Bilal Hameed | 2392 | 3911 | 267 | 1252 | 66 | 5.5k | |
| Hari S. Conjeevaram | 6765 | 7584 | 220 | 924 | 82 | 9.4k | |
| Samuele De Minicis | 3132 | 4166 | 282 | 1049 | 56 | 7.0k | |
| Naga Chalasani | 2077 | 3191 | 392 | 969 | 68 | 5.0k | |
| Marcello Persico | 3172 | 4154 | 509 | 954 | 197 | 6.3k | |
| Jay H. Lefkowitch | 4327 | 4817 | 328 | 509 | 136 | 8.3k | |
| Frank A. Anania | 2575 | 5535 | 134 | 2046 | 81 | 8.5k | |
| Patrick Hillon | 2613 | 2885 | 429 | 546 | 135 | 5.4k | |
| I M Murray-Lyon | 6176 | 5274 | 652 | 383 | 71 | 8.8k | |
| Coleman I. Smith | 6449 | 7749 | 76 | 1470 | 52 | 9.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...